Coronary Artery Disease in Aging Women: A Menopause of Endothelial Progenitor Cells?

Medical Clinics of North America

Volumn 96, Issue 1, 2012, Pages 93-102

  Hutter, Randolph ^a   Badimon, Juan Jose ^a   Fuster, Valentin ^a,b   Narula, Jagat ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Atherogenesis; Coronary artery disease; Endothelium; Women

Indexed keywords

ESTROGEN RECEPTOR; VASCULOTROPIN RECEPTOR;

AGING; ATHEROGENESIS; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL HOMING; CELL PROLIFERATION; CORONARY ARTERY DISEASE; ENDOTHELIAL PROGENITOR CELL; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; NONHUMAN; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SMOOTH MUSCLE FIBER; STROMA CELL;

CARDIOTONIC AGENTS; CORONARY ARTERY DISEASE; ENDOMETRIUM; ENDOTHELIAL GROWTH FACTORS; ESTROGEN REPLACEMENT THERAPY; FEMALE; GONADAL STEROID HORMONES; HUMANS; MENOPAUSE; MENSTRUAL CYCLE; NEOVASCULARIZATION, PHYSIOLOGIC; REPRODUCTION; STEM CELLS; WOMEN'S HEALTH;

EID: 84857772397     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2012.01.008     Document Type: Review

References (82)

1. Badimon J.J., Zaman A., Helft G., et al. Acute coronary syndromes: pathophysiology and preventive priorities. Thromb Haemost 1999, 82:997-1004.
2. Fuster V., Fayad Z.A., Badimon J.J. Acute coronary syndromes: biology. Lancet 1999, 353(Suppl 2):SII5-SII9.
3. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
4. Burke A.P., Farb A., Malcom G.T., et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997, 336:1276-1282.
5. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
6. Rafii S., Meeus S., Dias S., et al. Contribution of marrow-derived progenitors to vascular and cardiac regeneration. Semin Cell Dev Biol 2002, 13:61-67.
7. Asahara T., Masuda H., Takahashi T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.
8. Fujiyama S., Amano K., Uehira K., et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 2003, 93:980-989.
9. Griese D.P., Ehsan A., Melo L.G., et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: Implications for cell-based vascular therapy. Circulation 2003, 108:2710-2715.
10. Takahashi T., Kalka C., Masuda H., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434-438.
11. Walter D.H., Rittig K., Bahlmann F.H., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002, 105:3017-3024.
12. Rosenzweig A. Circulating endothelial progenitors-cells as biomarkers. N Engl J Med 2005, 353:1055-1057.
13. Werner N., Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?. Arterioscler Thromb Vasc Biol 2006, 26:257-266.
14. Hristov M., Erl W., Weber P.C. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003, 23:1185-1189.
15. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005, 111:2981-2987.
16. Urbich C., Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004, 95:343-353.
17. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353:999-1007.
18. Ouyang P., Michos E.D., Karas R.H. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. J Am Coll Cardiol 2006, 47:1741-1753.
19. Berg G., Mesch V., Boero L., et al. Lipid and lipoprotein profile in menopausal transition. Effects of hormones, age and fat distribution. Horm Metab Res 2004, 36:215-220.
20. Matthan N.R., Jalbert S.M., Lamon-Fava S., et al. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status. Arterioscler Thromb Vasc Biol 2005, 25:1691-1696.
21. Shimabukuro M., Higa N., Asahi T., et al. Fluvastatin improves endothelial dysfunction in overweight postmenopausal women through small dense low-density lipoprotein reduction. Metabolism 2004, 53:733-739.
22. Hu F.B., Grodstein F., Hennekens C.H., et al. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 1999, 159:1061-1066.
23. Mondul A.M., Rodriguez C., Jacobs E.J., et al. Age at natural menopause and cause-specific mortality. Am J Epidemiol 2005, 162:1089-1097.
24. Ayres S., Abplanalp W., Liu J.H., et al. Mechanisms involved in the protective effect of estradiol-17beta on lipid peroxidation and DNA damage. Am J Physiol 1998, 274:E1002-E1008.
25. Ren J., Hintz K.K., Roughead Z.K., et al. Impact of estrogen replacement on ventricular myocyte contractile function and protein kinase B/Akt activation. Am J Physiol Heart Circ Physiol 2003, 284:H1800-H1807.
26. Strehlow K., Rotter S., Wassmann S., et al. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 2003, 93:170-177.
27. Sumino H., Ichikawa S., Itoh H., et al. Hormone replacement therapy decreases insulin resistance and lipid metabolism in Japanese postmenopausal women with impaired and normal glucose tolerance. Horm Res 2003, 60:134-142.
28. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999, 340:1801-1811.
29. Davidson M.H., Testolin L.M., Maki K.C., et al. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women. Arch Intern Med 1997, 157:1186-1192.
30. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002, 288:321-333.
31. Rossouw J.E., Prentice R.L., Manson J.E., et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007, 297:1465-1477.
32. Wenger N.K. Coronary heart disease: an older woman's major health risk. BMJ 1997, 315:1085-1090.
33. Cignarella A., Paoletti R., Puglisi L. Direct effects of estrogen on the vessel wall. Med Res Rev 2001, 21:171-184.
34. Bulut D., Albrecht N., Imohl M., et al. Hormonal status modulates circulating endothelial progenitor cells. Clin Res Cardiol 2007, 96:258-263.
35. Hoetzer G.L., MacEneaney O.J., Irmiger H.M., et al. Gender differences in circulating endothelial progenitor cell colony-forming capacity and migratory activity in middle-aged adults. Am J Cardiol 2007, 99:46-48.
36. Reynolds L.P., Killilea S.D., Redmer D.A. Angiogenesis in the female reproductive system. FASEB J 1992, 6:886-892.
37. Ferrara N., Chen H., Davis-Smyth T., et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 1998, 4:336-340.
38. Goede V., Schmidt T., Kimmina S., et al. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab Invest 1998, 78:1385-1394.
39. Losordo D.W., Isner J.M. Estrogen and angiogenesis: a review. Arterioscler Thromb Vasc Biol 2001, 21:6-12.
40. Shweiki D., Itin A., Neufeld G., et al. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993, 91:2235-2243.
41. Folkman J., Klagsbrun M. Angiogenic factors. Science 1987, 235:442-447.
42. Masuda H., Kalka C., Takahashi T., et al. Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ Res 2007, 101:598-606.
43. Bonatz G., Hansmann M.L., Buchholz F., et al. Macrophage- and lymphocyte-subtypes in the endometrium during different phases of the ovarian cycle. Int J Gynaecol Obstet 1992, 37:29-36.
44. Fernandez-Shaw S., Clarke M.T., Hicks B., et al. Bone marrow-derived cell populations in uterine and ectopic endometrium. Hum Reprod 1995, 10:2285-2289.
45. Hutter R., Carrick F.E., Valdiviezo C., et al. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation 2004, 110:2430-2435.
46. Iwakura A., Luedemann C., Shastry S., et al. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 2003, 108:3115-3121.
47. Fadini G.P., Avogaro A., Agostini C. Critical assessment of putative endothelial progenitor phenotypes. Exp Hematol 2007, 35:1479-1480. [author reply: 1481-2].
48. Fadini G.P., Coracina A., Baesso I., et al. Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 2006, 37:2277-2282.
49. Fadini G.P., de Kreutzenberg S.V., Coracina A., et al. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J 2006, 27:2247-2255.
50. Prater D.N., Case J., Ingram D.A., et al. Working hypothesis to redefine endothelial progenitor cells. Leukemia 2007, 21:1141-1149.
51. Madeddu P., Emanueli C., Pelosi E., et al. Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J 2004, 18:1737-1739.
52. Pelosi E., Valtieri M., Coppola S., et al. Identification of the hemangioblast in postnatal life. Blood 2002, 100:3203-3208.
53. Schatteman G.C., Dunnwald M., Jiao C. Biology of bone marrow-derived endothelial cell precursors. Am J Physiol Heart Circ Physiol 2007, 292:H1-H18.
54. Yoder M.C., Mead L.E., Prater D., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109:1801-1809.
55. Hamada H., Kim M.K., Iwakura A., et al. Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation 2006, 114:2261-2270.
56. Heil M., Ziegelhoeffer T., Mees B., et al. A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ Res 2004, 94:573-574.
57. Iwakura A., Shastry S., Luedemann C., et al. Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation 2006, 113:1605-1614.
58. Strehlow K., Werner N., Berweiler J., et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003, 107:3059-3065.
59. Dumont D.J., Fong G.H., Puri M.C., et al. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn 1995, 203:80-92.
60. Nishikawa S.I., Nishikawa S., Hirashima M., et al. Progressive lineage analysis by cell sorting and culture identifies FLK1+ve-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development 1998, 125:1747-1757.
61. Shalaby F., Rossant J., Yamaguchi T.P., et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995, 376:62-66.
62. Vittet D., Prandini M.H., Berthier R., et al. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood 1996, 88:3424-3431.
63. Aicher A., Zeiher A.M., Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 2005, 45:321-325.
64. Imanishi T., Hano T., Nishio I. Estrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity. J Hypertens 2005, 23:1699-1706.
65. Bolego C., Vegeto E., Pinna C., et al. Selective agonists of estrogen receptor isoforms: new perspectives for cardiovascular disease. Arterioscler Thromb Vasc Biol 2006, 26:2192-2199.
66. Gargett C.E., Lederman F.L., Lau T.M., et al. Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium. Hum Reprod 1999, 14:2080-2088.
67. Li X.F., Gregory J., Ahmed A. Immunolocalisation of vascular endothelial growth factor in human endometrium. Growth Factors 1994, 11:277-282.
68. Shifren J.L., Tseng J.F., Zaloudek C.J., et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996, 81:3112-3118.
69. Heissig B., Hattori K., Dias S., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002, 109:625-637.
70. Mints M., Jansson M., Sadeghi B., et al. Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient. Hum Reprod 2008, 23:139-143.
71. Taylor H.S. Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA 2004, 292:81-85.
72. Jin D.K., Shido K., Kopp H.G., et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 2006, 12:557-567.
73. Lapidot T., Dar A., Kollet O. How do stem cells find their way home?. Blood 2005, 106:1901-1910.
74. Sengenes C., Miranville A., Maumus M., et al. Chemotaxis and differentiation of human adipose tissue CD34+/CD31- progenitor cells: role of stromal derived factor-1 released by adipose tissue capillary endothelial cells. Stem Cells 2007, 25:2269-2276.
75. Yamaguchi J., Kusano K.F., Masuo O., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328.
76. Elsheikh E., Sylven C., Ericzon B.G., et al. Cyclic variability of stromal cell-derived factor-1 and endothelial progenitor cells during the menstrual cycle. Int J Mol Med 2011, 27:221-226.
77. Matsubara K., Abe E., Matsubara Y., et al. Circulating endothelial progenitor cells during normal pregnancy and pre-eclampsia. Am J Reprod Immunol 2006, 56:79-85.
78. Freedman S.B., Isner J.M. Therapeutic angiogenesis for ischemic cardiovascular disease. J Mol Cell Cardiol 2001, 33:379-393.
79. Isner J.M. Still more debate over VEGF. Nat Med 2001, 7:639-641.
80. Assmus B., Rolf A., Erbs S., et al. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail 2010, 3:89-96.
81. Leistner D.M., Schmitt J., Palm S., et al. Intracoronary administration of bone marrow-derived mononuclear cells and arrhythmic events in patients with chronic heart failure. Eur Heart J 2011, 32:485-491.
82. Arbustini E., Dal B., Morbini P., et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 1999, 82(3):269-272.